Foghorn Therapeutics Inc (FHTX)

Foghorn Therapeutics Inc (FHTX) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $110M; returns 1 day -0.5%, 1 week +8.1%, 1 year -48.7%.

Foghorn Therapeutics Inc. (FHTX) is a clinical-stage biotechnology company focused on discovering and developing novel medicines targeting genetically determined dependencies within the chromatin regulatory system. Their approach involves modulating gene expression to treat serious diseases, particularly in oncology.

Groups FHTX belongs to

• Biotechnology
• Oncology
• Clinical Stage
• Clinical Stage Biotech
• Healthcare
• Drug Discovery
• Epigenetics
• Precision Medicine
• Cancer Therapeutics

FHTX financial model: income statement, cash flow and balance sheet